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ARTICLE
Patient-speciﬁc multiscale computational ﬂuid dynamics
assessment of embolization rates in the hybrid Norwood:
effects of size and placement of the reverse Blalock–Taussig
shunt1
Ray Prather, John Seligson, Marcus Ni, Eduardo Divo, Alain Kassab, and William DeCampli

Abstract: The hybrid Norwood operation is performed to treat hypoplastic left heart syndrome. Distal arch obstruction may
compromise ﬂow to the brain. In a variant of this procedure, a synthetic graft (reverse Blalock–Taussig shunt) is placed between
the pulmonary trunk and innominate artery to improve upper torso blood ﬂow. Thrombi originating in the graft may embolize
to the brain. In this study, we used computational ﬂuid dynamics and particle tracking to investigate the patterns of particle
embolization as a function of the anatomic position of the reverse Blalock–Taussig shunt. The degree of distal arch obstruction
and position of particle origin inﬂuence embolization probabilities to the cerebral arteries. Cerebral embolization probabilities
can be reduced by as much as 20% by optimizing graft position, for a given arch geometry, degree of distal arch obstruction, and
particle origin. There is a tradeoff, however, between cerebral pulmonary and coronary embolization probabilities.
Key words: computational ﬂuid dynamics, hypoplastic left heart syndrome, hybrid Norwood, lumped parameter model, patient
speciﬁc, reverse Blalock–Taussig shunt, thrombus.
Résumé : La technique hybride de l’intervention de Norwood est utilisée pour traiter le syndrome d’hypoplasie du cœur gauche.
L’obstruction de l’arc aortique distal peut compromettre le ﬂux au cerveau. Dans une variante de cette intervention, on place un
greffon synthétique (anastomose de Blalock–Taussig inversée) entre l’artère pulmonaire et le tronc artériel brachio-céphalique
en vue d’améliorer le ﬂux sanguin vers le haut du torse. Les thrombus provenant du greffon pourraient ainsi s’emboliser dans
le cerveau. Dans ces travaux, nous avons étudié les schémas d’embolisation des particules en fonction de la position anatomique
de l’anastomose de Blalock–Taussig inversée à l’aide de la mécanique des ﬂuides numérique et du repérage des particules. Le
degré d’occlusion de l’arc aortique distal et le lieu d’origine des particules inﬂuencent les probabilités d’embolisation dans les
artères cérébrales. Il est possible de faire diminuer les probabilités d’embolisation cérébrale de jusqu’à 20 % en optimisant la
position d’un greffon donné en fonction de la géométrie de l’arc en question, du degré d’occlusion distale de l’arc et de l’origine
des particules. Il faut toutefois faire un compromis entre les probabilités d’embolisation cérébrale, pulmonaire et coronarienne.
[Traduit par la Rédaction]
Mots-clés : mécanique des ﬂuides numérique, syndrome d’hypoplasie du cœur gauche, Norwood hybride, modèle de paramètres
concentrés, propre au patient, anastomose de Blalock-Taussig inversée, thrombus.

Introduction
Hypoplastic left heart syndrome (HLHS) is a congenital heart
anomaly with an incidence of about 1 in 2000 live births. It is
characterized by hypoplasia of the left ventricle, aortic arch hypoplasia, mitral atresia or stenosis, and aortic valve atresia or stenosis (Benjamin et al. 2017; Roger et al. 2012). Therapeutic options
for HLHS are heart transplantation and strategies of staged reconstruction aimed at establishing a viable uni-ventricular circulation. The hybrid Norwood (HN) has emerged as a promising
strategy for the ﬁrst-stage reconstruction (Galantowicz et al. 2008;
Bacha et al. 2006). HN avoids cardiopulmonary bypass and consists of branch pulmonary artery banding (Baker et al. 2013), stent-

ing of the ductus arteriosus, and balloon atrial septostomy,
shifting the risk of major surgery to an older age with the expectation of improved survival as well as neurological outcome. The
addition of a reverse Blalock–Taussig shunt (RBTS) sutured to the
pulmonary trunk and anastomosed to the innominate artery aims
to reinstate blood ﬂow to the cerebral and coronaries arteries in
cases of severe distal aortic arch stenosis (Caldarone et al. 2005,
2007) and as described on Nationwide Children’s Hospital’s website (https://www.nationwidechildrens.org/) (Nationwide Children’s
Hospital 2018). Our previous work aimed to understand the nature of
the complex HN ﬂow and to gauge the effectiveness of the RBTS to
restore ﬂow in cases of severe distal arch stenosis (Ceballos 2015;
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Fig. 1. Hybrid Norwood nominal ﬂuid domain geometry (inlet,
pulmonary trunk; LPA, left pulmonary artery; RPA, right pulmonary
artery; RcorA, right coronary artery; LcorA, left coronary artery; LSA,
left subclavian Artery; LCA, left carotid artery; RCA, right carotid
artery; RSA, right subclavian artery; da, descending aorta). [Color
online.]

Ceballos et al. 2012, 2015). This work is substantiated by similar
results (Bove et al. 2008; Hsia et al. 2011). These studies demonstrated ﬂow patterns such as recirculation zones, stagnation, and
abnormal shear stresses. Combined with the fact that the RBTS is
synthetic (usually consisting of polytetraﬂuoroethylene), these
ﬂow patterns put the RBTS at risk for thrombosis and thromboembolization. In this study, we conducted an analysis of thromboembolic probabilities for thrombi originating in various locations
within the RBTS to establish the effect of shunt size and placement position on these rates (Seligson 2017). We speciﬁcally explored shunt sizes of 3, 3.5, and 4 mm. Our aim is to establish
whether the RBTS size and placement can be tailored to reduce
incidence of stroke due to shunt thromboembolism.

Materials and methods
Anatomic modelling
We constructed an anatomic model of the HN vasculature from
a real patient’s computed tomography scan using Mimics (Materialise, Leuven, Belgium), then added the RBTS using Solidworks
(Dassault Systemes, Waltham, Massachusetts, USA) (Fig. 1). We
meshed the resulting anatomic model, then calculated the ﬂow
through the domain using computational ﬂuid dynamics (CFD)
using StarCCM+ (CDAdapco-Siemens, Plano, Texas, USA).
Flow calculations
To calculate the ﬂow ﬁeld, StarCCM+ employs a ﬁnite volume
approach to solve the continuity and momentum equations (eqs. 1
and 2). A second-order temporal discretization has been used to
retain accuracy in computing the discretized transient terms.
Convective terms are resolved with a second-order scheme as well.
(1)

ⵜ · Vជ ⫽ 0

(2)



⭸Vជ
⫹ (Vជ · ⵜ)Vជ ⫽ ⫺ⵜp ⫹ ⵜ2Vជ
⭸t

A segregated ﬂow solver is implemented to solve the
3-dimensional ﬂow ﬁeld. Both velocity and pressure are under-
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Fig. 2. Computational ﬂuid dynamics (CFD) – lumped parameter
model (LPM) coupling scheme guided by a Java macro regulating the
data exchange between the CFD code and the LPM circuit. BC, boundary
conditions; RK, Runge-Kutta solver; Rs, ﬂow resistances. [Color online.]

relaxed to maintain a stable solution. Blood was modeled as a
non-Newtonian incompressible ﬂuid with a density of  = 1060 kg/m3
and dynamic viscosity, 共␥˙ 兲, using a 3-parameter modiﬁed CarreauYasuda model (eq. 3).
(3)

(␥˙ ) ⫽ ∞ ⫹ (0 ⫺ ∞)

1
1

[1 ⫹ (␥˙ )2] 3

Here, ␥˙ is the shear rate and the model constants are the viscosity
at high shear rate ∞, the viscosity at zero shear rate 0, and
relaxation time  depend on blood hematocrit (Long et al. 2005;
Good et al. 2016). We used values corresponding to a 40% hemtatocrit: ∞ = 4 cP, 0 = 8 cP, and  = 0.313 s.
Boundary conditions are provided by a lumped parameter
model (LPM) circuit that is coupled to the CFD (Figs. 2 and 3). The
LPM circuit is as outlined in previous work carried out by our
group (Prather 2015; Prather et al. 2017) and substantiated by similar approaches. The LPM provides 1-dimensional inlet mass ﬂow
rates and stagnation pressure to the ﬂuid domain while the CFD
returns surface averaged pressure and mass ﬂow rates at locations
corresponding to the circuit nodes back to the LPM along with
initial conditions. The LPM model described by Ceballos (2015) and
Ceballos et al. (2012) based on the work carried out by Faragallah
et al. (2012) was modiﬁed to reﬂect a more physiologically correct
ﬂow split at the coronaries. Sankaran et al. (2012) observed a 70%–
30% split between the left and right coronary arteries. To achieve
this, the arterial coronary resistances were manipulated to either
enhance (left) or reduce (right) ﬂow while retaining the appropriate overall coronary ﬂow to cardiac output ratio. Figure 3 displays
the full LPM circuit.
Following initial tuning of the LPM model, the LPM–CFD coupling is used to iteratively adjust the boundary conditions to attain consistent and physiologically correct ﬂow ﬁeld. Once
pressure and mass ﬂow rates variations fall below threshold values, the ﬂow ﬁeld is deemed converged. The ﬂow ﬁeld is in turn
used to track particles in the Lagrangian frame as described in the
sequel.
For each conﬁguration, a structured mesh is generated, including a 7-cell thick prism layer, which extrudes from the domain
wall (Fig. 4). Volumetric reﬁnement at the pulmonary bands as
well as curvature reﬁnement was carried out due to the sharp
Published by NRC Research Press
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Fig. 3. Full lumped parameter model circuit used for all conﬁgurations. [Color online.]
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Fig. 4. Sample full domain mesh (left) and prism layer mesh in pulmonary artery (right). [Colour online.]

Table 1. Mesh data for all reported geometries.
Stenosis
level

Shunt size and
placement

Cell
count

0%

3 mm, nominal
3.5 mm, nominal
4 mm, nominal
3 mm, nominal
3.5 mm, nominal
4 mm, nominal
3.5 mm, option 1
3.5 mm, option 2
3.5 mm, option 3

2 012 153
2 022 188
2 045 489
2 325 633
2 342 107
2 271 028
612 585
616 846
579 635

90%

0%

Fig. 5. Particle release grids along shunt (injection_grid 1, proximal;
injection_grid 2, medial; injection_grid 3, distal). [Color online.]

lumen area reduction to retain computational accuracy. Table 1
summarizes the data relative to cell count for each model analyzed. A grid independence study not reported here was carried
out for the new conﬁgurations.
Given the Eulerian–Lagrangian coupling and the mesh count,
this problem was parallelized on a local cluster where the domain
was portioned on an average of 16 CPUs per simulation. A total of
3 heart cycles per simulation for a total physical time of 1.5 s (0.5 s
per heart cycle) are simulated.
Particle tracking
Particle motions were calculated in the Lagrangian frame
(eq. 4). We accounted for blood-to-particle and particle-to-wall interactions while neglecting particle-to-particle interaction. Forces
on the particles included gravity, drag, Saffman lift and added
mass (eqs. 5 and 6).

(4)
(5)
(6)

mp

ជ
dV
p
¡
¡
⫽ Fbody ⫹ Fsurface
dt

兺 F៝
兺 F៝

body

⫽ F៝gravity

surface

⫽ F៝drag ⫹ F៝added mass ⫹ F៝Saffman

The added mass accounts for the inertia of the surrounding volume of ﬂuid displaced by the particles as they accelerate or decelerate in the ﬂow, while the Saffman lift is a shear lift force
perpendicular to the ﬂow direction that originates from inertia
effects in the viscous ﬂow around the particle. We modelled
thrombi (particles) as solid spheres of set density  = 1116.73 kg/m3

and varying size between 1 mm and 2 mm in diameter. We investigated 3 separate particle origins, or “release locations” — at the
proximal, or pulmonary trunk end, at the distal, or innominate
artery end, and midway between these within the graft (Fig. 5). We
introduced particles in the ﬂuid domain by means of injector
grids (Fig. 5) that release particles randomly in time and in space
over the injector cross-section grids. Particles are assumed to have
zero initial velocity.
The particle release rate per injector is prescribed by a timebased table that has a portion of the points in the grid release a
particle at random time-steps throughout the run. The number of
selected grid points per injector releasing a particle at a time-step
is determined by a ﬁxed value, namely the point inclusion probability. The particle time-table ensures temporal randomness
while StarCCM+ allows randomization of spatial release at every
time-step. Particle interactions are limited to particle–ﬂuid and
particle–wall, the latter regulated by restitution coefﬁcents for
perfectly elastic collisions. Particles are tracked in the anatomic
Published by NRC Research Press
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Fig. 6. Proposed shunt positioning to investigate embolization rate
optimization: (a) increased distal anastomosis angle of implantation,
(b) rotated shunt out of plane with a shallow anastomosis angle, and
(c) shortened shunt anastomosis located proximal to the aortic and
pulmonary trunk roots. [Color online.]
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implantation (Fig. 6a); (ii) rotated shunt out of plane with a shallow anastomosis angle (Fig. 6b); and (iii) shortened shunt anastomosis located proximal to the aortic and pulmonary trunk roots
(Fig. 6c). The nominal RBTS graft implantation (Fig. 4) is at 90° to
the innominate. Starting from the nominal graft placement, we
moved to (i) increase angle of anastomosis at the innominate artery by 36° while keeping the graft on the same graft centerline
plane, (ii) rotate the shunt out of plane by 70° aligning the outlet
centerline with the centerline of the distal aortic arch, and
(iii) translate the distal anastomosis 17 mm from the innominate
artery takeoff caudally along the ascending aorta towards the
coronary arteries.

Results

domain and boundary counters at the outlets allow evaluation of
particle transport statistics.
We investigated models with 0% and 90% distal aortic arch stenosis, and 3 mm, 3.5 mm, and 4 mm diameter RBTS grafts for each
degree of arch stenosis. Based on previous studies conducted by
our group (Ceballos 2015; Ceballos et al. 2012, 2015) that determined that a 3.5 mm shunt ensures enhanced cerebral vessel and
coronary perfusion, 3 alternate orientation options of the RBTS
with 3.5 mm diameter with 0% aortic arch stenosis case were
generated. The alternate geometries vary in anastomosis location
and angle as follows: (i) increased distal anastomosis angle of

2

Particle data were collected for all nominal geometries and the
optional models. Figures 7–10 display sample particle tracks for
the 3.5 mm shunt size, 0% distal arch stenosis, and for 1 mm
particle size. Similar representations were obtained for all graft
diameters. Each column contains a sequence of images for a single
heart cycle for particles released at the proximal, medial, and
distal grid in the graft with an adjacent heart cycle plot to display
the sampling instant. Comparable displays for particle tracks for
other diameters may be found in the supplementary material
accompanying this manuscript2.
For particle release from the proximal grid, the effect of diastolic back ﬂow in the shunt can be clearly seen for all graft and
particle sizes studied. Particles are transported from the shunt to
the pulmonary trunk. Shortly thereafter, however, the heart cycle
enters the systolic phase and strong ventricular ejection pushes
particles towards the ductus arteriosus. This pattern presents 2 main
potential outcomes as particles move towards the descending aorta: they may embolize to the pulmonary arteries (corresponding
to the clinical scenario of pulmonary thromboembolism) or they
proceed to the descending aorta and may embolize downstream
in the lower body circulation. With increasing graft diameters,
the portion of the shunt lumen experiencing back ﬂow decreases,
allowing for more particles to travel towards the distal portion of
the graft. In systole, this results in a much larger number of particles being pushed into the aortic arch and in particular into the
right cerebral vessels. Larger particles carry more momentum,
which may result in deviation from ﬂow streamlines especially
near distal shunt anastomosis and vessel bifurcations.
Particles originating from the midline grid experience graft
back ﬂow as well for all graft and particle sizes. Because of their
initial position, however, these particles infrequently reach the
pulmonary trunk. In fact, they tend to behave as particles originating from the proximal grid, both remaining within the graft
lumen for a greater fraction of the cardiac cycle. Particles that do
travel upstream enter the aortic arch and right cerebral vessels
and, presumably, to the brain. Additionally, with larger graft diameter and (or) larger particle size, fewer particles experience
retrograde ﬂow in diastole.
The most evident feature of particles released from the distal
grid is an increased probability of transport to the aortic arch and
branching vessels. This is true for all graft and particles sizes
studied. The clinical consequence potentially would be cerebral or
coronary embolism. In particular, particles released in the aortic
arch and experiencing larger residence time in the arch (especially in diastole) have a greater probability of embolization to the
coronary arteries (Fig. 7). If any particle happens to be caught in
back ﬂow during diastole, they may behave as particles originating from the midline of the graft, but for the most part, in systole
they will be transported antegrade and out of the graft. The few

Supplementary data are available with the article through the journal Web site at http://nrcresearchpress.com/doi/suppl/10.1139/cjpp-2018-0002.
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Fig. 7. Coronary streamlines combined with 1 mm particles. [Color online.]

particles that do travel retrograde out of the graft may ultimately
reach the descending aorta by way of the ductus arteriosus.
Overall, examination of the ﬂow patterns illustrates the “double jeopardy” of clot formation in the RBTS — particles traveling
antegrade and beyond the distal end of the graft will embolize to
either the coronary arteries or arch vessels (including cerebral
vessels), potentially resulting in myocardial injury or stroke. Particles traveling retrograde and beyond the proximal end of the
graft will embolize either to the descending aorta or pulmonary
arteries, resulting potentially in either abdominal organ embolization or pulmonary embolism. A rigorous patient-speciﬁc optimization scheme would optimize RBTS position to minimize
particle embolization to the cerebral and coronary arteries, with
the hope that embolization to the lung or descending aorta will be
less clinically consequential.
Overall, the 0% stenosis case involves higher embolization rates
(Fig. 11, top). For the 0% stenosis case, RBTS graft diameter did not
signiﬁcantly impact the percentage of total embolic events with
55.92% for 3 mm graft, 54.34% for a 3.5 mm graft and 54.22% for a
4 mm graft. Focusing on pulmonary embolism, the 3 mm graft
displayed lower probabilities than the larger grafts. In general,
the 3 mm graft resulted in lower probability of coronary embolization, followed by the 3.5 mm graft. Qualitatively there seemed
to be an inverse relationship between cerebral and coronary arterial particle embolization probability.
The 90% stenosis case showed lower overall embolization probability than that in the 0% stenosis case (Fig. 11, bottom). In this
case, graft diameter was an important factor, with embolization
probabilities of 33.95% for a 3 mm shunt, 44.61% for a 3.5 mm
shunt, and 49.01% for a 4 mm shunt. On the other hand, pulmonary embolism does not appear strongly correlated to graft diameter. Coronary embolization probability was directly related to
increasing shunt diameter. In general, there was a direct relationship between cerebral and coronary embolization probabilities.

As shown in Fig. 11, graft diameter clearly plays a role in potentially reducing thromboembolic events. The sharp reduction of
more than 10% observed with a 3 mm shunt 90% distal arch stenosis proves that surgical techniques can be optimized in this case
to reduce stroke even though in the absence of distal arch stenosis, shunt size does not signiﬁcantly impact thromboembolic
rates. A near 2% reduction in coronary embolization probability
with the 3 mm graft also supports the notion that graft diameter
is a factor in embolization probabilities. Regarding the probability of pulmonary embolization, for the 0% stenosis case, there was
no signiﬁcant dependence of embolization probability on graft
diameter. For the 90% stenosis case, the 3.5 mm and 4 mm grafts
are associated with reduced pulmonary embolization probabilities, as compared with those of the 3.0 mm graft.
To further investigate the graft positional factors that may inﬂuence embolization probabilities to the right cerebral vessels,
we varied distal anastomosis angle and proximal and distal anastomosis locations on their respective vessels. Starting from the
nominal graft placement, we moved to increase angle of anastomosis at the innominate artery by 36° while keeping the graft on
the same graft centerline plane (option 1), rotate the shunt out of
plane by 70° to have an outlet normal in line with the aortic arch
(option 2), and translate the distal anastomosis 17 mm from the
innominate artery takeoff caudally along the ascending aorta towards the coronary arteries (option 3). We held the graft diameter
constant at 3.5 mm between the 3 options in Fig. 6 based on
previous studies (Ceballos et al. 2015; Ceballos 2015) that examined 3.0, 3.5, and 4 mm RBTS shunt diameters and found that the
3.5 mm graft provided the best option from the point of view of
restoring coronary blood ﬂow in the presence of distal arch stenosis while providing the most favorable hemodynamics when
implanted prophylactically.
Overall, option 3 shows the lowest cumulative thromboembolic
probability with 52.70%, while option 2 has 59.30% and option 1
Published by NRC Research Press
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Fig. 8. Nominal 3.5 mm reverse Blalock–Taussig shunt 0% stenosis 1 mm proximal particle release. [Color online.]
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Fig. 9. Nominal 3.5 mm reverse Blalock–Taussig shunt 0% stenosis 1 mm medial particle release. [Color online.]
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Fig. 10. Nominal 3.5 mm reverse Blalock–Taussig shunt 0% stenosis 1 mm distal particle release. [Color online.]
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Fig. 11. Embolization rates for the patient-speciﬁc model with 0%
stenosis (top) and 90% distal arch stenosis (bottom). BT, Blalock–Taussig.
[Color online.]
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ies causing them to ultimately be transported to the coronaries.
For the 3 options, stroke risk and pulmonary embolism risk appear to be inversely correlated.
When comparing the nominal case for a 3.5 mm graft with 0%
stenosis with the new conﬁgurations thromboembolic incidence
can be reduced from 54.34% to 52.70% (option 3). However, incidence may also be increased from 54.34% to 63.23% (option 1).
Upon closer inspection, beneﬁcial effect becomes more evident.
Option 3 shows more than a 2-fold decrease in embolization probability from 47.68% to 22.41%. Option 2 displays as much as a 7%
decrease in embolization probability. Option 1 shows an increase
in cerebral embolization probability but a noticeable reduction in
pulmonary embolization probability from 5.59% to 3.98%. Pulmonary embolism incidence for options 2 and 3 increases up to 3
times the nominal amount. Coronary embolization probabilities
consistently increase across all option conﬁgurations by as much
as 13 times (option 2) from 1.07% up to 13.22%. These new conﬁgurations target the reduction of stroke risk by redirecting thrombi
travelling out of the shunt away from the cerebral vessels. Particles transported into the aortic arch (aimed away from the cerebral vessels) either ﬂow towards the distal portion of the aortic
arch or ﬂow towards the aortic root, causing higher coronary
embolization rates.
Stroke risk can be reduced by modifying the graft anastomosis
conﬁguration. However, there is a clear tradeoff between reducing stroke incidence and increased myocardial infarction and pulmonary embolisms. Within the limited exploration in this study,
option 3 may be the best tradeoff. While halving stroke probability (from 47.68% to 22.41%), coronary embolization is 10-fold larger
(from 1.07% to 11.82%) and pulmonary embolism grow 3-fold (from
5.59% to 18.47%). Additional variance may be introduced on a caseby-case basis for different patient-speciﬁc geometries.

Discussion
Fig. 12. Embolization rates for the 0% distal arch stenosis 3.5 mm
shunt patient-speciﬁc model for the 3different options. [Color online.]

has 63.23% (Fig. 12). Option 3 leads to the lowest stroke risk being
nearly half that of options 1 and 2. Option 3, however, displays a
pulmonary embolism risk more than 3 times higher compared
with the other 2 options. Option 1 is most favorable in this case.
This sharp distinction is entirely due to the graft placement and
length. As the graft length is much less than that in the nominal
case, throughout a heart cycle, a larger amount of particles enter
the pulmonary trunk; therefore, having a high probability of embolizing to the pulmonaries. Option 1 results in the lowest rate of
myocardial infarction among the 3 conﬁgurations, while options 2 and 3 present more than twice that amount. In option 3,
larger coronary embolization rates are due to the distal shunt
anastomosis proximity to the aortic root. Option 2 leads to particles released in the aortic arch to experience large residence time
in the volume between the innominate take-off and the coronar-

The HN procedure is performed as a ﬁrst stage palliation of
HLHS. A complication of the HN is distal arch obstruction, which
compromises ﬂow to the coronaries and upper systemic circulation. As a countermeasure, a synthetic graft, the RBTS, is introduced between the pulmonary trunk and the innominate artery
to enhance ﬂow to the aortic arch. Previous studies have compared the hemodynamics of the HN and standard Norwood repair
(Hsia et al. 2011), explored the effects of pulmonary banding in the
HN (Baker et al. 2013), explored the ability of the RBTS to restore
coronary blood ﬂow in the presence of various degrees of distal
arch stenosis (Ceballos et al. 2012), and explored shunt ﬂow with
and without distal arch obstruction suggesting that a 3.5 mm
diameter graft provides the best compromise shunt size when the
RBTS is implemented prophylactically (Ceballos et al. 2015; Ceballos
2015). Moreover, the latter computational hemodynamic studies
have also suggested that the RBTS graft has the potential to develop pathological ﬂows that may be thrombogenic. Thrombi
originating in the shunt risk embolization to the brain. In this
study, we analyze the correlation between shunt size and placement to embolization probabilities. Furthermore, we target the
reduction of stroke rates by modifying the graft conﬁguration to
redirect particles away from the cerebral circulation. The aim is to
identify factors inﬂuencing embolization rates. The multiscale
CFD model utilized in this study implemented a non-Newtonian
blood model, a patient-speciﬁc geometry, and pulsatile ﬂow conditions. The CFD ﬂuid domain was coupled to a LPM and iterated
to ensure a converged boundary condition before introducing the
Lagrangian phase tracking model for transport of thrombi.
Our multi-scale patient-speciﬁc HN model predicts that for
nominal RBTS implantation, shunt size has little inﬂuence on
thromboembolic incidence when no stenosis is present. Stroke
probability decreases 15%–20% when distal arch obstruction is
present. Moreover, for a severe 90% distal arch stenosis, stroke
Published by NRC Research Press
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rates are sensitive to shunt size. Closer inspection reveals that
graft size can have beneﬁcial inﬂuence on stroke probability in
this case, and more than 10% reduction can be achieved by utilizing a smaller shunt size of 3 mm for severe distal arch obstruction.
The rates of pulmonary and coronary embolism are not signiﬁcantly different with variation of shunt size; however, these rates
are higher with 90% stenosis as compared with no stenosis. Pulmonary embolism rates double while coronary embolism quadruple in the presence of severe stenosis. Consequently, in the
presence of distal arch stenosis, our current results suggest that a
3 mm RBTS could be considered as advantageous in reducing
cerebral and coronary thromboembolic events while offering no
signiﬁcant improvement in pulmonary embolization rates.
In case of prophylactic implementation of the RBTS in the absence of distal arch stenosis, we explored whether improvement
in thromboembolism rates can be achieved by optimally tailoring
the shunt implantation. Here, we focus on the 3.5 mm RBTS as
suggested by (Ceballos et al. 2015; Ceballos 2015) and we investigated several discrete shunt placements and orientations. In option 1, steepening the distal arch anastomosis angle relative to the
nominal implantation in an attempt to redirect the thrombus
away from cerebral vessels (Fig. 6) had adverse effects of increasing stroke probability by 6% and coronary embolization by 5% but
a positive effect of reducing pulmonary embolism rates by 2%,
leading to a combined embolism rate (63.23%) that was higher
than nominal (54.34%). In option 2, rotating the graft out of plane
reduced stroke probability by 7%, but augmented coronary embolism probability by 13% leading to a combined embolism rate
(59.3%) that was also higher than nominal (54.34%). However, in
option 3, translating the graft closer to the aortic root reduced
stroke probability by 25%, although pulmonary embolism doubled and coronary embolism probability grew 10-fold relative to
the nominal case resulting in a reduced combined embolism rate
(52.7%) relative the nominal (54.34%). In the absence of arch stenosis, manipulation of the 3.5 mm graft implantation lead to
signiﬁcant improvement in stroke risk that was accompanied by
acute increases in other thromboembolic events. Our results suggest that optimizing RBTS placement in the absence of arch stenosis from the perspective of reducing thromboembolisms involves
competing factors and may require careful trade-off in optimization on a patient-speciﬁc basis.
Our study was limited to a single-patient geometry. Beneﬁcial
modiﬁcations to the RBTS implantation found in this study may
not yield a similar outcome for other patients. Future work should
consider a larger number of patient-speciﬁc geometries. Limitations of the model used in this study include rigid vessel walls.
Future studies may consider compliant vessels by generating wall
thickness and using a suitable arterial mechanical model in a ﬂuid–
structure interaction multiscale hemodynamics model. However,
such calculations are highly computationally intensive and may
not be suitable for clinical applications. Another limitation in the
current work, is that the thrombi are modeled as point particles in
a Lagrangian phase with elastic particle-to-wall interactions. Future
work could consider introducing particle-to-particle interactions and
partially elastic collisions. Moreover, more complex discrete element model or a dynamic ﬂuid–body Interaction model may be
used to simulate particles with discrete dimensions interacting
with each other and the walls accounting for damping and potential deformation. Such options also signiﬁcantly add to the computational burden of the simulation.
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